You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: March 29, 2024

Claims for Patent: 8,338,100


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 8,338,100
Title:Isolated genomic polynucleotide fragments from chromosome 12 that encode human carboxypeptidase M
Abstract: The invention is directed to isolated genomic polynucleotide fragments that encode human carboxypeptidase M and human mouse double minute 2 homolog, vectors and hosts containing these fragments and fragments hybridizing to noncoding regions as well as antisense oligonucleotides to these fragments. The invention is further directed to methods of using these fragments to obtain human carboxypeptidase M and human mouse double minute 2 homolog and to diagnose, treat, prevent and/or ameliorate a pathological disorder.
Inventor(s): Ryan; James (Augusta, GA)
Assignee: Ryogen LLC (Suffern, NY)
Application Number:13/244,474
Patent Claims:1. A method of identifying a nucleotide sequence variant of a 5'-noncoding region, 3'-noncoding region or intron region of SEQ ID NO:3 or its full complementary sequence comprising (a) isolating genomic nucleic acid from a sample and (b) determining the presence or absence of a nucleotide sequence variation in said genomic nucleic acid by comparing the nucleotide sequence of SEQ ID NO:3 with the nucleotide sequence of the isolated genomic nucleic acid and establishing if and where a difference occurs between the two nucleic acid sequences thereby identifying a nucleotide sequence variant of SEQ ID NO:3 or its full complement.

2. The method according to claim 1, wherein said variant encodes a protein having human Carboxypeptidase M activity.

3. A method of identifying variants of SEQ ID NO:3 comprising (a) isolating genomic nucleic acid from a subject and (b) determining the presence or absence of a variant in said genomic DNA using an isolated nucleic acid molecule consisting of a fragment of a non-coding region of SEQ ID NO:3, wherein said non-coding region is selected from the group consisting of a 5'-noncoding region shown in sequence segment 1-16440 of SEQ ID NO:3, a 3'-non coding region shown in sequence segment 93042-99680 of SEQ ID NO:3 and an intron region shown in sequence segments, 16797-63584, 63687-77521, 77693-79076, 79263-79981, 80153-82428, 82582-90405, 90556-92798 of SEQ ID NO:3, noncoding fragment is at least 20 contiguous nucleotides in length or a full complement of said isolated nucleic acid molecule.

4. A method of identifying variants of SEQ ID NO:3 comprising (a) isolating genomic DNA nucleic acid from a subject and (b) determining the presence or absence of a variant in said genomic nucleic acid using an isolated nucleic acid molecule consisting of a sequence segment of SEQ ID NO:3, wherein said segment is at least 20 contiguous nucleotides in length consisting of a contiguous coding and non-coding nucleic acid sequence of SEQ ID NO:3.

5. The method according to claim 4, wherein said genomic nucleic acid is amplified.

Details for Patent 8,338,100

Applicant Tradename Biologic Ingredient Dosage Form BLA Approval Date Patent No. Expiredate
Merck Sharp & Dohme Corp. INTRON A interferon alfa-2b For Injection 103132 06/04/1986 ⤷  Try a Trial 2023-06-27
Merck Sharp & Dohme Corp. INTRON A interferon alfa-2b For Injection 103132 ⤷  Try a Trial 2023-06-27
Merck Sharp & Dohme Corp. INTRON A interferon alfa-2b Injection 103132 ⤷  Try a Trial 2023-06-27
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Approval Date >Patent No. >Expiredate

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.